Verywell Health on MSN3d
HIV vs. AIDS: How They Differ and Why Early Treatment Matters
People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...
The Trump Administration's HIV Prevention Contradictions
The new head of the Department of Health and Human Services (HHS), Robert F. Kennedy, Jr., has expressed some doubts about ...
Simulation model shows potential affordability of preventive HIV therapy for infants
HIV infections are lifelong and can weaken the immune system, causing a patient to be more susceptible to infection and ...
Rolling Out7d
5 crucial reasons not to delay HIV treatment
Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and reduces costs ...
The Citizen11h
Fresh hope in quest for HIV cure
The clinical trial, dubbed FRESH and conducted in Durban, South Africa, revealed that four out of 20 women with acute HIV ...
Immune response may be harnessed to control HIV, primary trial results suggest
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
The Citizen on MSN10h
First HIV cure clinical trial in Africa shows promise in women
Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...
Science Daily13d
Researchers develop method to identify dormant cells that carry HIV
The findings were published in Nature Communications on March 6. HIV is a virus that attacks cells in the body fighting off infections, thus weakening the immune system. Antiretroviral therapies can ...
Federal funding cuts threaten Colorado’s plan to reduce HIV infections
The Colorado Department of Public Health and Environment projected that new HIV diagnoses will total 482 in 2024 — virtually ...
technologynetworks12d
New Method Identifies Hidden Immune Cells That Harbor HIV
The findings were published in Nature Communications on March 6. HIV is a virus that attacks cells in the body fighting off infections, thus weakening the immune system. Antiretroviral therapies can ...
Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections ...